Signal Bay Inc (OTCMKTS:SGBY) has confirmed that it is expanding into the Portland Oregon market in pursuit of new opportunities for growth. The announcement comes days after the provider of cannabis consulting operations and laboratory services announced it had exceeded the 700-business accounts milestone.

Signal Bay Expansion Drive

With the expansion into the Portland Oregon area, the company is hoping to exceed the 1000 mark on business accounts seen as a key driver or revenue going forward. Given that the company has vast experience in the cannabis industry, CEO, William Wardrop, expects a smooth sailing as the race to bolster market share heats up.

Signal Bay is relying on the support of another key player in the business to make its mark in the Portland area. Given the firm’s network of connections, the company remains confident of the expansion drive fueling further growth.

Expansion in Portland Oregon comes on the heels of the acquisition of Oregon Analytical Services LLC early in the year that expanded the company’s testing footprint into Eugene Oregon. Early in the year, the company also expanded its cannabis-testing footprint into the Emerald Triangle in Northern California.

Waldrop Robust Growth Sentiments

The chief executive remains bullish about the company’s growth prospects given the ongoing drive on the legalization of marijuana for medical use across the United States. Focus according to the executive shifts towards refining the production process in anticipation of a growth in demand for the firm’s cannabis testing facilities as more businesses come online.

Given Signal Bay Inc (OTCMKTS:SGBY) growing revenue base, Mr. Waldrop believes the stock is undervalued especially on ramping up business accounts. The executive has also quashed rumors that they are considering a reverse stock split in the near future. According to the executive, they may only increase the number of common or preferred shares in the market while putting the interest of current shareholders first.

Why Lotus Bio-Technology Development Corp (OTCMKTS:LBTD) Signed Deal With HC

Lotus Bio-Technology Development Corp (OTCMKTS:LBTD) confirmed about its joint development and marketing contract with ‘Hunan Cangshi Biological Technology Co. Limited’. The associate is a manufacturer, proprietor and developer of viable natural items that are manufactured using organic herbs. There is a special team in place to look after the cultivation process.

The President, Michael Palethorpe, reported that this contract is a major achievement for the company. It offers them a big opportunity to associate with a leading firm that has a similar goal and aligned values. Both companies intend to progress together in establishing viable, natural goods. HC is a choice subordinate with robust operations that will boost Lotus’s global sales strategy.

It products are not only organic and environment friendly, but they are also affordable and of premium quality. The finalized contract is projected to have a positive impact on next quarter sales.

Previous articleNewLead Holdings Ltd (OTCMKTS:NEWLF) Ship On Auction Over Unpaid Promissory Note
Next articleMedical Marijuana Inc (OTCMKTS:MJNA) Receives Additional Permits to Export Into in Mexican Market
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg,,, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.